Profil
Nils Martin Malmsten is the founder of DermaGen AB (founded in 2004) and Sista versen 26366 AB (founded in 2009).
He held the title of Director at both companies.
Currently, he is a Professor at the University of Uppsala.
Previously, he worked as a Principal at The Royal Society of Chemistry and Astra Arcus AB.
Postes actifs de Nils Martin Malmsten
| Sociétés | Poste | Début |
|---|---|---|
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Nils Martin Malmsten
| Sociétés | Poste | Fin |
|---|---|---|
Sista versen 26366 AB
Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Discovers treatments for inflammatory disorders | Fondateur | - |
Astra Arcus AB | Corporate Officer/Principal | - |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Corporate Officer/Principal | - |
DermaGen AB
DermaGen AB Pharmaceuticals: MajorHealth Technology Develops therapeutic peptides | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Commercial Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DermaGen AB
DermaGen AB Pharmaceuticals: MajorHealth Technology Develops therapeutic peptides | Health Technology |
Astra Arcus AB | |
Sista versen 26366 AB
Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Discovers treatments for inflammatory disorders | Health Technology |
















